Corteva, Inc. (NYSE:CTVA) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Corteva, Inc. (NYSE:CTVA) have received an average rating of “Moderate Buy” from the twenty-two analysts that are presently covering the stock, MarketBeat Ratings reports. Nine research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. The average twelve-month target price among brokers that have issued a report on the stock in the last year is $88.1429.

A number of brokerages have recently issued reports on CTVA. Wells Fargo & Company raised their price target on shares of Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a report on Tuesday, April 21st. Mizuho raised their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. CICC Research raised their price target on Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 13th. Oppenheimer raised their price target on Corteva from $86.00 to $89.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 22nd. Finally, Wall Street Zen downgraded Corteva from a “buy” rating to a “hold” rating in a research note on Saturday, February 7th.

Hedge Funds Weigh In On Corteva

Institutional investors and hedge funds have recently made changes to their positions in the business. Activest Wealth Management boosted its holdings in shares of Corteva by 118.3% in the third quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after buying an additional 200 shares during the last quarter. JPL Wealth Management LLC bought a new stake in Corteva during the third quarter valued at about $25,000. Westfuller Advisors LLC grew its holdings in Corteva by 2,764.3% during the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after purchasing an additional 387 shares during the period. Garton & Associates Financial Advisors LLC bought a new stake in Corteva during the fourth quarter valued at about $27,000. Finally, Bank of Jackson Hole Trust bought a new stake in Corteva during the fourth quarter valued at about $28,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA stock opened at $79.16 on Friday. Corteva has a one year low of $60.53 and a one year high of $85.63. The company’s 50-day moving average is $81.31 and its 200 day moving average is $73.92. The company has a market capitalization of $52.95 billion, a price-to-earnings ratio of 46.57, a price-to-earnings-growth ratio of 2.41 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, beating the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion for the quarter, compared to the consensus estimate of $4.64 billion. During the same period in the prior year, the firm posted $1.13 EPS. Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Sell-side analysts expect that Corteva will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be issued a $0.18 dividend. The ex-dividend date of this dividend is Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is presently 42.35%.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.